Vanessa Roldan

Associated Professor Hematology

Universidad de Murcia Facultad de Medicina

Spain

Research Interests

Explore related searches

Professors in Spain

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

About

Vanessa Roldan is an Associate Professor of Hematology at Universidad de Murcia Facultad de Medicina, Spain. Her research areas include venous thromboembolism triggers, anticoagulation quality, and the impact of lifestyle on cardiovascular events in patients with atrial fibrillation. She has contributed to significant studies regarding stroke risk assessment and clinical outcomes related to multimorbidity and frailty in atrial fibrillation patients.

Articles (20)

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2023

Year:

2023

Year:

2023

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Collaborators (5)

Juan Badimon

Professor Medicine/Cardiology

Icahn School of Medicine at Mount Sinai

UNITED STATES

View details

María del Pilar Ramos-Bratos

Universidad de Murcia

SPAIN

View details

José Miguel Rivera-Caravaca

Profesor Permanente Laboral

Universidad de Murcia

SPAIN

View details

Francisco Marin

Universidad de Murcia

SPAIN

View details

Manuel Anguita Sánchez

Universidad de Córdoba

SPAIN

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Vanessa Roldan

Research Interests

Explore related searches

Contact this professor

About

Articles (20)

Association between baseline adherence to a healthy lifestyle with ischemic and major cardiovascular events in patients with atrial fibrillation.

The Neutrophil-to-Lymphocyte Ratio Is an Independent Inflammatory Biomarker for Adverse Events in Patients With Atrial Fibrillation: Insights From the Murcia AF Project II (MAFP-II) Cohort Study

Stress, Partner Violence, and Coagulopathy: Unmasking New Triggers for Venous Thromboembolism

Quality of anticoagulation with vitamin K antagonists in Spain: A systematic review with meta-analysis of national registries.

What is the impact of dynamic score reassessment for stroke and bleeding risk outcome prediction in atrial fibrillation patients?

Poor clinical outcomes associated to multimorbidity, frailty and malnutrition in patients with atrial fibrillation.

Does One Size Fits All?

Real-world outcomes of tandem ASCT in newly diagnosed multiple myeloma patients with standard risk features: a single-center analysis.

Advances in the medical treatment and diagnosis of intracranial hemorrhage associated with oral anticoagulation.

Patients with atrial fibrillation and common exclusion criteria from clinical trials are at high risk of clinical events: the Murcia AF Project II (MAFP-II) cohort study.

Predicting Bleeding in Cancer-Associated Venous Thromboembolism: Another Milestone Achieved

Use of Direct Acting Oral Anticoagulants in Elderly Patients with Atrial Fibrillation: A Multicenter, Cross-Sectional Study in Spain

Non-embolic outcomes in patients with cardiovascular disease and atrial fibrillation treated with rivaroxaban.

Imaging in atrial fibrillation: A way to assess atrial fibrosis and remodeling to assist decision-making.

Polypharmacy and adverse events in atrial fibrillation: Main cause or reflection of multimorbidity?

Predicting performance of the HAS-BLED and ORBIT bleeding risk scores in patients with atrial fibrillation treated with Rivaroxaban: Observations from the prospective EMIR Registry.

Editorial: New horizons in the management of patients with atrial fibrillation: Interactions with the gastrointestinal system.

Rivaroxaban for the prevention of outcomes in patients with atrial fibrillation in clinical practice: an indirect comparison of national and international registries.

Assessment and Mitigation of Bleeding Risk in Atrial Fibrillation and Venous Thromboembolism: Executive Summary of a European and Asia-Pacific Expert Consensus Paper.

Diagnostic and therapeutic potential of miRNAs in cardiovascular disease: a clinical reality?

Collaborators (5)

Juan Badimon

María del Pilar Ramos-Bratos

José Miguel Rivera-Caravaca

Francisco Marin

Manuel Anguita Sánchez

Make your next move.